Sector consensus Black Diamond Therapeutics, Inc.

Stocks

Market Closed - Nasdaq 16:00:00 2026-08-27 EDT			5-day change	1st Jan Change
2.270 ^USD	0.00%		+5.58%	-6.58%

08-05	Black Diamond Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
06-29	Black Diamond Therapeutics, Inc.(NasdaqGS:BDTX) added to Russell 2000 Index	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Financial estimates divergence	Average Target P.	Objective/dr gap	Nbr of analysts
BLACK DIAMOND THERAPEUTICS, INC.		10	+340.53%	7
WUXI APPTEC CO., LTD.		183.92	+14.99%	18
ARGENX SE	-	1,124.35	+6.36%	15
BIONTECH SE		103.92	+8.86%	20
INSMED INCORPORATED		200.18	+64.91%	22
WUXI BIOLOGICS (CAYMAN) INC.		47.29	+9.22%	24
PHARMAESSENTIA CORPORATION		1,341.89	-13.98%	8
GENMAB A/S		2,410.46	+11.23%	15
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.		614.54	+17.17%	18
EXELIXIS, INC.		53	-4.09%	17
ARROWHEAD PHARMACEUTICALS, INC.		110.18	+24.37%	11
MADRIGAL PHARMACEUTICALS, INC.		678.06	+24.71%	16
SUMMIT THERAPEUTICS INC.		21.05	+99.65%	13
AKESO, INC.		142.08	+63.74%	21
CYTOKINETICS, INCORPORATED		109.9	+41.08%	20
VAXCYTE, INC.		109	+78.24%	9
CRINETICS PHARMACEUTICALS, INC.		85.5	+0.77%	10
IMMUNITYBIO, INC.		12.75	+51.79%	4
REMEGEN CO., LTD.		104.11	+47.18%	16
SPYRE THERAPEUTICS, INC.		119.71	+27.88%	14
Average		379.09	+45.73%	15
Weighted average by Cap.		511.59	+22.16%	16